Atia A. Hamid

459 total citations
11 papers, 384 citations indexed

About

Atia A. Hamid is a scholar working on Molecular Biology, Reproductive Medicine and Genetics. According to data from OpenAlex, Atia A. Hamid has authored 11 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Reproductive Medicine and 4 papers in Genetics. Recurrent topics in Atia A. Hamid's work include Ovarian cancer diagnosis and treatment (4 papers), Reproductive System and Pregnancy (3 papers) and Virus-based gene therapy research (2 papers). Atia A. Hamid is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Reproductive System and Pregnancy (3 papers) and Virus-based gene therapy research (2 papers). Atia A. Hamid collaborates with scholars based in Japan. Atia A. Hamid's co-authors include Masaki Mandai, Ikuo Konishi, Kanako Nanbu, K Matsushita, Y Tsuruta, Takahide Mori, Hideki Kuroda, Hisao Kuroda, K Nanbu and Shingo Fujii and has published in prestigious journals such as Cancer, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Atia A. Hamid

11 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atia A. Hamid Japan 8 230 118 87 68 50 11 384
Gabriele Leder Germany 8 149 0.6× 67 0.6× 72 0.8× 65 1.0× 70 1.4× 12 319
Asomi Sato Japan 11 248 1.1× 205 1.7× 103 1.2× 71 1.0× 88 1.8× 15 511
Herta Bettendorf Germany 12 217 0.9× 65 0.6× 41 0.5× 84 1.2× 22 0.4× 15 387
Martin Flack United States 8 211 0.9× 233 2.0× 80 0.9× 50 0.7× 112 2.2× 8 555
Rana Varshochi United Kingdom 7 339 1.5× 111 0.9× 29 0.3× 134 2.0× 125 2.5× 7 516
A. de Goeij Netherlands 7 146 0.6× 92 0.8× 28 0.3× 115 1.7× 105 2.1× 8 486
Teruhiko Tamaya Japan 12 216 0.9× 150 1.3× 21 0.2× 55 0.8× 117 2.3× 15 383
Maria M. Szwarc United States 15 231 1.0× 215 1.8× 63 0.7× 297 4.4× 241 4.8× 37 654
Diana Monsivais United States 16 294 1.3× 392 3.3× 132 1.5× 365 5.4× 93 1.9× 38 829
Rachel Beery Israel 12 210 0.9× 51 0.4× 14 0.2× 91 1.3× 123 2.5× 33 399

Countries citing papers authored by Atia A. Hamid

Since Specialization
Citations

This map shows the geographic impact of Atia A. Hamid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atia A. Hamid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atia A. Hamid more than expected).

Fields of papers citing papers by Atia A. Hamid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atia A. Hamid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atia A. Hamid. The network helps show where Atia A. Hamid may publish in the future.

Co-authorship network of co-authors of Atia A. Hamid

This figure shows the co-authorship network connecting the top 25 collaborators of Atia A. Hamid. A scholar is included among the top collaborators of Atia A. Hamid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atia A. Hamid. Atia A. Hamid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mandai, Masaki, Ikuo Konishi, Atia A. Hamid, et al.. (2003). Loss of Fhit protein expression in high-grade and advanced stage endometrial carcinomas.. PubMed. 23(3C). 2837–43. 3 indexed citations
2.
Kusakari, Takashi, Masaki Mandai, Y Tsuruta, et al.. (2003). C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. British Journal of Cancer. 89(12). 2293–2298. 30 indexed citations
3.
Hamid, Atia A., Masaki Mandai, Jun Fujita, et al.. (2003). Expression of Cold-Inducible RNA-Binding Protein in the Normal Endometrium, Endometrial Hyperplasia, and Endometrial Carcinoma. International Journal of Gynecological Pathology. 22(3). 240–247. 36 indexed citations
6.
Tsuruta, Y, Masaki Mandai, Ikuo Konishi, et al.. (2001). Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines. European Journal of Cancer. 37(4). 531–541. 32 indexed citations
7.
Kuroda, Hideki, Masaki Mandai, Ikuo Konishi, et al.. (1998). Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: Possible role of up-regulation of insulin-like growth factor-1 by hCG. International Journal of Cancer. 76(4). 571–578. 49 indexed citations
8.
Nanbu, Kanako, Ikuo Konishi, Masaki Mandai, et al.. (1998). Prognostic Significance of Heat Shock Proteins HSP70 and HSP90 in Endometrial Carcinomas. Cancer Detection and Prevention. 22(6). 549–555. 82 indexed citations
9.
Mandai, Masaki, Ikuo Konishi, Hisao Kuroda, et al.. (1998). Expression of abnormal transcripts of the FHIT (Fragile Histidine Triad) gene in ovarian carcinoma. European Journal of Cancer. 34(5). 745–749. 10 indexed citations
10.
Kuroda, Hideki, Masaki Mandai, Ikuo Konishi, et al.. (1998). Human chorionic gonadotropin (hCG) inhibits cisplatin‐induced apoptosis in ovarian cancer cells: Possible role of up‐regulation of insulin‐like growth factor‐1 by hCG. International Journal of Cancer. 76(4). 571–578. 4 indexed citations
11.
Yamamoto, Shinichi, Ikuo Konishi, Y Tsuruta, et al.. (1997). Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecological Endocrinology. 11(6). 371–381. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026